Cargando…
Potentiation of melphalan activity against a murine tumour by nitroimidazole compounds.
The activity against murine anaplastic MT tumours of the chemotherapeutic agent melphalan, either alone or in combination with one of 6 nitroimidazole compounds, was assayed using an in vivo-in vitro tumour excision assay. The melphalan alone proved cytotoxic to the tumour, whereas relatively little...
Autores principales: | Sheldon, P. W., Batten, E. L., Adams, G. E. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1982
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2011202/ https://www.ncbi.nlm.nih.gov/pubmed/7138761 |
Ejemplares similares
-
Effect of the nitroimidazole Ro 03-8799 on the activity of chemotherapeutic agents against a murine tumour in vivo.
por: Sheldon, P. W., et al.
Publicado: (1984) -
Potentiation of the anti-tumour effect of melphalan by the vasoactive agent, hydralazine.
por: Stratford, I. J., et al.
Publicado: (1988) -
Radiosensitization of C3H Mouse Mammary Tumours by a 2-Nitroimidazole Drug
por: Sheldon, P. W., et al.
Publicado: (1974) -
Radiation Damage Mechanisms of Chemotherapeutically Active Nitroimidazole Derived Compounds
por: Chiarinelli, Jacopo, et al.
Publicado: (2019) -
Novel benzoxaborole, nitroimidazole and aminopyrazoles with activity against experimental cutaneous leishmaniasis
por: Van Bocxlaer, Katrien, et al.
Publicado: (2019)